Switch theme
Sign up to access all valuation multiples
Andon Health Co Ltd is a China-based company. It is principally engaged in the research and development, manufacture and distribution of medical instruments. Its main products include a blood pressure monitor, blood glucose monitor, TENS, electrical muscle stimulator, electronic pulse massager, and a digital thermometer.
1995
n/a
LTM Revenue $372M
LTM EBITDA $170M
$1.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Andon Health has a last 12-month revenue (LTM) of $372M and a last 12-month EBITDA of $170M.
In the most recent fiscal year, Andon Health achieved revenue of $360M and an EBITDA of $311M.
Andon Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Andon Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $372M | XXX | $360M | XXX | XXX | XXX |
| Gross Profit | $264M | XXX | $254M | XXX | XXX | XXX |
| Gross Margin | 71% | XXX | 71% | XXX | XXX | XXX |
| EBITDA | $170M | XXX | $311M | XXX | XXX | XXX |
| EBITDA Margin | 46% | XXX | 86% | XXX | XXX | XXX |
| EBIT | $275M | XXX | $98.1M | XXX | XXX | XXX |
| EBIT Margin | 74% | XXX | 27% | XXX | XXX | XXX |
| Net Profit | $219M | XXX | $232M | XXX | XXX | XXX |
| Net Margin | 59% | XXX | 64% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Andon Health's stock price is CNY 38 (or $5).
Andon Health has current market cap of CNY 17.9B (or $2.5B), and EV of CNY 11.3B (or $1.6B).
See Andon Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.6B | $2.5B | XXX | XXX | XXX | XXX | $0.46 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Andon Health has market cap of $2.5B and EV of $1.6B.
Andon Health's trades at 4.4x EV/Revenue multiple, and 5.0x EV/EBITDA.
Equity research analysts estimate Andon Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Andon Health has a P/E ratio of 11.3x.
See valuation multiples for Andon Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.5B | XXX | $2.5B | XXX | XXX | XXX |
| EV (current) | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| EV/Revenue | 4.2x | XXX | 4.4x | XXX | XXX | XXX |
| EV/EBITDA | 9.2x | XXX | 5.0x | XXX | XXX | XXX |
| EV/EBIT | 5.7x | XXX | 16.0x | XXX | XXX | XXX |
| EV/Gross Profit | 5.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 11.3x | XXX | 10.7x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 12.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAndon Health's last 12 month revenue growth is 15%
Andon Health's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Andon Health's rule of 40 is 68% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Andon Health's rule of X is 83% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Andon Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Margin | 46% | XXX | 86% | XXX | XXX | XXX |
| EBITDA Growth | 64% | XXX | 6% | XXX | XXX | XXX |
| Rule of 40 | 68% | XXX | 101% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 83% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Andon Health acquired XXX companies to date.
Last acquisition by Andon Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Andon Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Andon Health founded? | Andon Health was founded in 1995. |
| Where is Andon Health headquartered? | Andon Health is headquartered in China. |
| Is Andon Health publicy listed? | Yes, Andon Health is a public company listed on SHE. |
| What is the stock symbol of Andon Health? | Andon Health trades under 002432 ticker. |
| When did Andon Health go public? | Andon Health went public in 2010. |
| Who are competitors of Andon Health? | Similar companies to Andon Health include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Andon Health? | Andon Health's current market cap is $2.5B |
| What is the current revenue of Andon Health? | Andon Health's last 12 months revenue is $372M. |
| What is the current revenue growth of Andon Health? | Andon Health revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Andon Health? | Current revenue multiple of Andon Health is 4.2x. |
| Is Andon Health profitable? | Yes, Andon Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Andon Health? | Andon Health's last 12 months EBITDA is $170M. |
| What is Andon Health's EBITDA margin? | Andon Health's last 12 months EBITDA margin is 46%. |
| What is the current EV/EBITDA multiple of Andon Health? | Current EBITDA multiple of Andon Health is 9.2x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
